CRYBA2 c.446+1G>A
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal. | ||
| Consequence | canonical splice-site (±1/±2) | predicted loss-of-function |
|---|---|---|
| Splicing | ||
| Splice region | donor +1 | canonical splice dinucleotide (donor +1) · inside the BP7-excluded zone |
| SpliceAI | Δ0.98 | donor loss · deltas |
| Pangolin | Δ0.76 | loss · gain 0.19 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 1.7 | GERP 0.9, phastCons 1 |
| Overall | ||
| CADD | 24.6 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.183% | 548 |
| Remaining individualsnot grpmax-eligible | 0.0592% | 1,688 |
| European (non-Finnish)grpmax | 0.0407% | 2,456 |
| Middle Eastern | 0.0165% | 6,054 |
| African / African-American | 0.0107% | 9,377 |
| Finnishnot grpmax-eligible | 0.00312% | 32,004 |
| East Asian | 0.00223% | 44,818 |
| South Asian | 0.0011% | 90,990 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CRYBA2
- Coding
- c.446+1G>A
- MANE Select
- NM_057093
- Type
- single nucleotide variant
- Location
- chr2:218990851 (GRCh38)
- Gene constraint
- LOEUF 1.372 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 93.12
Disease context
cataract 42 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Early onset non-syndromic cataract (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Onset
- Infancy, Neonatal
Similar variants
- CRYBA2 c.303+5G>A Uncertain significance ★ same condition
- CRYBA2 p.Ala80Thr Uncertain significance ★★ ⚠ same type
- CRYBA2 c.303+127A>G Benign ★★ same type
- CRYBA2 c.304-16T>C Benign ★★ same type
- CRYBA2 p.Ala10Pro Uncertain significance ★ ⚠ same type
- CRYBA2 p.Ala34Glu Uncertain significance ★ ⚠ same type
- CRYBA2 p.Ala6Ser Uncertain significance ★ ⚠ same type
- CRYBA2 p.Arg107Cys Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cryba2-c-446-plus-1g-a (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown